Department of Oncology-Pathology
At the Department of Oncology-Pathology (OnkPat), we conduct advanced cancer research to develop new ways of preventing and treating a wide range of cancers. We also educate the next generation of researchers and clinicians at all levels, from undergraduate to doctoral training. In addition, we are responsible for key research infrastructures in precision medicine and proteomics, as well as Sweden’s national biobank for childhood cancer research.
News
Upcoming events
Related centers
Photo: Getty Images.Centre for Medical Radiation Science
Karolinska Institutet, KTH Royal Institute of Technology, Stockholm University and Region Stockholm are establishing a new centre for medical radiation science in Stockholm. The centre will be hosted by the Department of Oncology-Pathology.
Photo: Creative Commons CC0Cancer Research KI
Cancer Research KI is an overarching umbrella organisation and single point of entry to cancer research at Karolinska Institutet, that includes some 250 research groups. The aim is to bring together top-level cancer scientists from different disciplines, with the overall goal to generate new discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.
Photo: Angiola HarryBRECT - Breast Cancer Theme Center
BRECT aims to increase our understanding of critical steps in breast cancer development and therapy.
Photo: n/aCancer Core Europe
Karolinska Institutet is one of the seven leading cancer centers that have joined forces to form the European cancer association Cancer Core Europe.
KI operational delegate: Christina von Gertten
The Swedish Childhood Tumor Biobank
The Swedish Childhood Tumor Biobank
The Swedish Childhood Tumor Biobank (Barntumörbanken, BTB) is a national research infrastructure supporting childhood cancer research through the collection, storage and analysis of biological samples and associated data. Hosted by the Department of Oncology-Pathology at Karolinska Institutet and operated in close collaboration with Karolinska University Hospital, BTB brings together expertise from across the research and healthcare sectors. The sample collection is managed by Biobank Stockholm, genomic analyses are performed in partnership with SciLifeLab, and the entire initiative is funded by the Swedish Childhood Cancer Fund. By providing authorised researchers with access to high-quality samples and data, BTB helps drive new knowledge and better treatments for children with cancer.